[HTML][HTML] Obesity and type 2 diabetes mellitus: Connections in epidemiology, pathogenesis, and treatments

R Ruze, T Liu, X Zou, J Song, Y Chen, R Xu… - Frontiers in …, 2023 - frontiersin.org
The prevalence of obesity and diabetes mellitus (DM) has been consistently increasing
worldwide. Sharing powerful genetic and environmental features in their pathogenesis …

Metabolites as regulators of insulin sensitivity and metabolism

Q Yang, A Vijayakumar, BB Kahn - Nature reviews Molecular cell …, 2018 - nature.com
The cause of insulin resistance in obesity and type 2 diabetes mellitus (T2DM) is not limited
to impaired insulin signalling but also involves the complex interplay of multiple metabolic …

Roles of diacylglycerols and ceramides in hepatic insulin resistance

MC Petersen, GI Shulman - Trends in pharmacological sciences, 2017 - cell.com
Although ample evidence links hepatic lipid accumulation with hepatic insulin resistance,
the mechanistic basis of this association is incompletely understood and controversial …

Contribution of specific ceramides to obesity-associated metabolic diseases

P Hammerschmidt, JC Brüning - Cellular and Molecular Life Sciences, 2022 - Springer
Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play
specialized regulatory roles in cellular metabolism depending on their characteristic fatty …

[HTML][HTML] The role of C16: 0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach

S Raichur, B Brunner, M Bielohuby, G Hansen… - Molecular …, 2019 - Elsevier
Objective Ectopic fat deposition is associated with increased tissue production of ceramides.
Recent genetic mouse studies suggest that specific sphingolipid C16: 0 ceramide produced …

Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool

AF Babu, S Csader, V Männistö, MM Tauriainen… - Scientific Reports, 2022 - nature.com
The mechanisms by which exercise benefits patients with non-alcoholic fatty liver disease
(NAFLD), the most common liver disease worldwide, remain poorly understood. A non …

The role of ceramides in metabolic disorders: when size and localization matters

SM Turpin-Nolan, JC Brüning - Nature Reviews Endocrinology, 2020 - nature.com
Ceramide accumulation is a hallmark in the manifestation of numerous obesity-related
diseases, such as type 2 diabetes mellitus and atherosclerosis. Until the early 2000s …

Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism

J Liu, S Yue, Z Yang, W Feng, X Meng, A Wang… - Pharmacological …, 2018 - Elsevier
Given the high and increasing prevalence of obesity, the safe and effective treatment of
obesity would be beneficial. Here, we examined whether oral hydroxysafflor yellow A …

Roles of ceramides in non-alcoholic fatty liver disease

E Hajduch, F Lachkar, P Ferré, F Foufelle - Journal of clinical medicine, 2021 - mdpi.com
Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, ranging
from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Its prevalence is rapidly …

A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism

N Turner, XY Lim, HD Toop, B Osborne… - Nature …, 2018 - nature.com
Specific forms of the lipid ceramide, synthesized by the ceramide synthase enzyme family,
are believed to regulate metabolic physiology. Genetic mouse models have established C16 …